Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients

A Jayk Bernal, MM Gomes da Silva… - … England Journal of …, 2022 - Mass Medical Soc
patient at home shortly after diagnosis may be more practical and patient-friendly for
nonhospitalized persons; such agents would be important new tools in the Covid-19 treatment

Oral health in hospitalized and nonhospitalized community-dwelling elderly patients

H Pajukoski, JH Meurman, S Snellman-Gröhn… - Oral Surgery, Oral …, 1999 - Elsevier
… the need for diagnosing and treating periodontitis in elderly patients. On the other hand, …
, but its proper treatment is still expected to diminish the systemic effects of oral bacteremia. …

[HTML][HTML] Current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients

DV Parums - … science monitor: international medical journal of …, 2022 - ncbi.nlm.nih.gov
… for systemic treatment with interferons or nitazoxanide in hospitalized patients with COVID-…
, and/or azithromycin in non-hospitalized patients or hospitalized patients with COVID-19 [8]. …

Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19

J Hammond, H Leister-Tebbe, A Gardner… - … England Journal of …, 2022 - Mass Medical Soc
… For nonhospitalized patients with mild-to-moderate Covid-19, treatment options include
monoclonal antibodies, which are currently available under emergency use authorization by the …

COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients

S Bellino - Annals of medicine, 2022 - Taylor & Francis
… , molnupiravir or remdesivir in non-hospitalized patients with mild-to-… Therefore, in this setting
oral nirmatrelvir/ritonavir and … , initiation of oral antiviral treatments in hospitalized patients (…

Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial

AM Kaizer, NI Shapiro, J Wild, SM Brown… - International Journal of …, 2023 - Elsevier
… enrolled non-hospitalized adults with confirmed SARS-CoV-2 infection and six or fewer days
of acute respiratory infection symptoms who were randomized to either twice-daily oral LPV/…

Oral nirmatrelvir and ritonavir in nonhospitalized vaccinated patients with coronavirus disease 2019

S Ganatra, SS Dani, J Ahmad, A Kumar… - Clinical Infectious …, 2023 - academic.oup.com
… While a virologic rebound is known to occur in some treated patients [11], our findings
demonstrate that, even if a rebound did occur in some, it did not negate the benefit of NMV-r …

Oral Antimicrobial Therapy of Nonhospitalized Tuberculous Patients,

AB Robins, H Abeles, AD Chaves… - American Review of …, 1954 - atsjournals.org
… a method for readily treating nonhospitalized patients, and oral preparations have made its
… Under these circumstances, a study of oral antimicrobial therapy in nonhospitalized patients

The clinical efficacy and safety of anti-viral agents for non-hospitalized patients with COVID-19: a systematic review and network meta-analysis of randomized …

CC Lai, YH Wang, KH Chen, CH Chen, CY Wang - Viruses, 2022 - mdpi.com
… and utilized to treat non-hospitalized adults with mild to … patients were non-hospitalized,
unvaccinated patients with … five days of oral nirmatrelvir plus ritonavir [5], five days of oral

Characteristics of oral manifestations in symptomatic non-hospitalized COVID-19 patients: a cross-sectional study on a sample of the Saudi population

ZS Natto, M Afeef, D Khalil, D Kutubaldin… - … journal of general …, 2021 - Taylor & Francis
… We recommend that oral examinations of COVID-19 patients should be conducted as a
routine examination to investigate any possible correlation between the disease and the oral